Table 2 Selected risk factors for the HSV‐2 infection and adjusted HSV‐2 seroprevalence rates in Poland.
| No | HSV‐2 seroprevalence (%) | OR (95% CI) | ||
|---|---|---|---|---|
| Age group (years) | 15–24 | 630 | 6.0* | 1¶ |
| 25–49 | 1081 | 9.8* | 1.9 (1.3 to 2.7) | |
| 50–65 | 546 | 11.5* | 2.6 (1.7 to 4.1) | |
| Overall | 2257 | 9.3‡ | p for trend = 0.004 | |
| Sex | Male | 1039 | 9.8† | 1¶ |
| Female | 1218 | 9.7† | 1.4 (0.99 to 1.8) | |
| HSV‐1 serostatus | Negative | 227 | 9.8‡ | 1¶ |
| Positive | 2030 | 10.7‡ | 0.79 (0.48 to 1.3) | |
| Region in Poland | Mazowieckie | 835 | 8.3‡ | 1¶ |
| Lubelskie | 309 | 6.6‡ | 0.69 (0.41 to 1.2) | |
| Warminsko‐mazurskie | 458 | 5.9‡ | 0.72 (0.47 to 1.1) | |
| Zachodnio‐pomorskie | 655 | 13.4‡ | 1.7 (1.2 to 2.5) |
OR, multivariate odds ratio adjusted for age, gender, HSV‐1 serostatus, and region.
*Gender adjusted HSV‐2 seroprevalence; †age group adjusted HSV‐2 seroprevalence; ‡age group and gender adjusted HSV‐2 seroprevalence; CI: confidence interval, 1¶, reference.